The Ebola virus soluble glycoprotein contributes to viral pathogenesis by activating the MAP kinase signaling pathway.

Furuyama, Wakako; Shifflett, Kyle; Feldmann, Heinz; Marzi, Andrea

Furuyama, Wakako; Shifflett, Kyle; Feldmann, Heinz; Marzi, Andrea.

Afiliação

Furuyama W; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratories, Hamilton, Montana, United States of America.
Shifflett K; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratories, Hamilton, Montana, United States of America.
Feldmann H; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratories, Hamilton, Montana, United States of America.
Marzi A; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratories, Hamilton, Montana, United States of America.

PLoS Pathog ; 17(9): e1009937, 2021 09.

Article em En | MEDLINE | ID: mdl-34529738

Assuntos

Ebolavirus/patogenicidade; Doença pelo Vírus Ebola/metabolismo; Sistema de Sinalização das MAP Quinases/fisiologia; Proteínas Virais/metabolismo; Replicação Viral/fisiologia; Animais; Ebolavirus/metabolismo; Células HEK293; Humanos; Camundongos; Fatores de Virulência/metabolismo

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Virais / Replicação Viral / Doença pelo Vírus Ebola / Sistema de Sinalização das MAP Quinases / Ebolavirus Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google